Login to Your Account



Search

Search results

Pharma: Clinic Roundup

• Boehringer Ingelheim GmbH , of Ingelheim, Germany, presented data at the American College of Chest Physicians meeting in Chicago from Phase II and Phase III studies testing tiotropium in asthma. (BioWorld-Today-2013-10-29) ...

BioWorld Today - Staff - 2013-10-29 00:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Baxter International Inc. , of Deerfield, Ill., said it started dosing patients with malignant solid tumors in a Phase I study of a fully human recombinant anti-macrophage migration inhibitory factor (MIF) monoclonal antibody. (BioWo ...

BioWorld Today - Staff - 2012-09-06 00:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Sihuan Pharmaceutical Holdings Group Ltd. , of Hong Kong, said the China Food and Drug Administration accepted its application for clinical trial approval of pirotinib. In preclinical studies, the second-generation inhibitor, aimed at the treatment ...

BioWorld Today - Staff - 2013-10-11 00:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Pfizer Inc ., of New York, reported top-line results from two Phase III trials of tofacitinib, an oral Janus kinase (JAK) inhibitor being investigated to treat adults with moderate-to-severe chronic plaque psoriasis: OPT Compare (A3921080) and OP ...

BioWorld Today - Staff - 2013-10-10 00:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Takeda Pharmaceutical Co. Ltd. , of Osaka, Japan, disclosed results of a Phase I/II study of its intramuscular bivalent (GI/GII) norovirus vaccine candidate in healthy adult volunteers who were challenged with the most commonly occurring noroviru ...

BioWorld Today - Staff - 2013-10-07 00:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Abbvie Inc. , of Chicago, shared results of a posthoc analysis of a Phase II study of Humira (adalimumab) for patients with hidradenitis suppurativa. The analysis showed that Humira produced a significant response rate in patients with moderate ...

BioWorld Today - Staff - 2013-10-04 00:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Eli Lilly and Co. , of Indianapolis, disclosed positive patient-reported health outcomes from a Phase III trial of dulaglutide, an investigational, long-acting glucagon-like peptide 1 receptor agonist being studied as a once-weekly treatment for ...

BioWorld Today - Staff - 2013-09-27 00:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Pfizer Inc. , of New York, said a Phase IIIb withdrawal design study for Lyrica (pregabalin) in patients with inadequately treated painful diabetic peripheral neuropathy did not meet its primary endpoint, defined as the change in mean pain score ...

BioWorld Today - Staff - 2012-05-07 00:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• UCB SA , of Brussels, Belgium, reported post-hoc analyses of pivotal trials of Neupro (rotigotine transdermal system) in patients with restless legs syndrome (RLS)/Willis Ekbom disease, showing improvements with rotigotine vs. placebo in most of ...

BioWorld Today - Staff - 2012-04-26 00:00 - 0 comments - 0 attachments

Pharma: Clinic Roundup

• Janssen Research and Development LLC , of Raritan, N.J., a unit of Johnson & Johnson, said results from a 52-week analysis of a Phase III trial of Invokana (canagliflozin) showed substantial improvements in glycemic control for patients with Ty ...

BioWorld Today - Staff - 2013-09-25 00:00 - 0 comments - 0 attachments